Amyotrophic lateral sclerosis (ALS), or Charkot’s disease as it is commonly known as is a motor neuron disease and is a progressing ailment which eventually results in the weakening and atrophy of muscles and lasts for about two to five years. The disease is considered 100% fatal. The disease results in lesions in the central and peripheral motor neurons resulting in bulbar syndrome and in extreme conditions manifests in muscle atrophy. In English- speaking countries, this disease is known as Lou Gehrig’s disease.
Amyotrophic lateral sclerosis in patients brings about –
- Muscular Spasms
- Speech and swallowing disorders
- Balance disorders
- Reflexogenic zone expansion / increased deep reflexes
- Pathological reflexes
- Hanging foot
- Respiratory disorders
- Sudden attacks of involuntary laughter or cry
Stem Cell Treatment of ALS include complete diagnosis and determination of disease stage. With the help of proper treatment from us, patients get relief from respiratory failure, gastric stoma, artificial lung ventilation, dysphagia etc.
After FSC transplantation, around 70% of patients experience reducing weakness, improved appetite, enhanced mood, reduction in the intensity of spasticity and fasciculations etc. And within two months of the transplant, patients have noticed a significant improvement in muscle rigidity, normalization of reflexes, reduction in the number of fasciculation zones, better tolerance and reduction in intensity of dysphagia and dysarthria.
About 48% of the patients will need to repeat the course of the treatment during the year to sustain the positive results of the treatment. In one-fourth of the cases, patients will need periodic transplants of stem cells every 1.5 – 2 years
Fetal stem cells transplants does not fight the immediate cause of the disease. Having said that, it does has substantial influence on links of the pathological process which in turn slows down the disease progression.